References
- FeldmanHIHeldPJHutchinsonJTStoiberEHartiganMFBerlinJAHemodialysis vascular access morbidity in the United StatesKidney Int1993435109110968510387
- ChoudhuryDVascular access thrombosis prophylaxisSemin Dial200619433534216893413
- MannsBJBurgessEDParsonsHGSchaeferJPHyndmanMEScott-DouglasNWHyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patientsKidney Int19995513153209893142
- HeardKARussellTAAccess thrombosis, hospitalization, and hematocrit level in hemodialysis patientsNephrol Nurs J200027660761116649341
- FukasawaMMatsushitaKKamiyamaMThe methylenetetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patientsAm J Kidney Dis200341363764212612987
- LentzSRHomocysteine and cardiovascular physiologyCarmelRJacobsenDWHomocysteine in Health and DiseaseNew York, NYCambridge University Press2001
- SheminDLapaneKLBaussermanLPlasma total homocysteine and hemodialysis access thrombosis: a prospective studyJ Am Soc Nephrol19991051095109910232697
- MallamaciFBonannoGSeminaraGHyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patientsAm J Kidney Dis200545470270715806473
- MallamaciFZoccaliCTripepiGHyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patientsKidney Int200261260961411849403
- SulimanMEBárányPKalantar-ZadehKLindholmBStenvinkelPHomocysteine in uraemia – a puzzling and conflicting storyNephrol Dial Transplant2005201162115479750
- Den HeijerMBlomHJGerritsWBIs hyperhomocysteinemia a risk factor for recurrent venous thrombosis?Lancet199534589548828857707810
- FermoIVigano’ D’AngeloSParoniRMazzolaGCaloriGD’AngeloAPrevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive diseaseAnn Intern Med1995123107477537574192
- BousheyCJBeresfordSAOmennGSMotulskyAGA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesJAMA199527413104910577563456
- Bednarek-SkublewskaAPrzywaraSWronskiJKsiazekAInfluence of homocysteine on the function of native arteriovenous fistula in hemodialysis patientsDial Transplant20063510
- BowdenRGWyattFBWilsonRHomocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective studyJ Nephrol200215666667012495281
- BowdenRGWyattFBWilsonRWilbornCGentileMHomocysteine and vascular access thrombosis in a cohort of end-stage renal disease patientsRen Fail200426670971415600264
- ChenTCWangIKLeeCHHyperhomocysteinemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective studyInt J Clin Pract200660121596159916704682
- HojsRGorenjakMEkartRDvorsakBPecovnik-BalonBHomocysteine and vascular access thrombosis in hemodialysis patientsRen Fail200224221522212071595
- SirrsSDuncanLDjurdjevOHomocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationshipNephrol Dial Transplant199914373874310193830
- GoldwasserPMichelMACollierJPrealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survivalAm J Kidney Dis19932212152258322786
- DegouletPLegrainMRéachIMortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative studyNephron19823121031107121651